Here are five key points:
1. Known as the Freedom Disc, the device is a single-piece technology made of proprietary polymer permanently bonded between two titanium discs.
2. The core of the device simulates the stability and flexibility of a healthy human disc.
3. The Freedom Disc has been implanted in over 800 patients globally and has performed well on the European market.
4. Clinical results show the AxioMed discs display superior strength, durability and enhanced range of motion when compared to that of a healthy human disc.
5. KICVentures first acquired AxioMed in November 2014 thanks to Kingsley R. Chin, MD, an orthopedic spine surgeon and CEO of KICVentures.
More articles on devices and implants:
Medication use after hip replacement surgery decreases, study finds — 5 highlights
New robotic arm increases recovery time for hip and knee surgery — 3 key facts
FDA expands safety claim for Zimmer Biomet’s Gel-One Cross-linked Hyaluronate — 4 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
